. Author manuscript; available in PMC: 2013 Nov 20.

Published in final edited form as: J Nutr Biochem. 2009 Aug 27;21(8):695–701. doi: 10.1016/j.jnutbio.2009.04.003

Table 4.

The effect of β-glucan extracts on the in vitro intestinal uptake of 18:0, 18:2 and cholesterol under conditions where the UWL resistance was low (bulk phase was stirred at 600 rpm)

	In vitro intestinal uptake (nmol 100 mg⁻¹ min⁻¹)
	Control	Extract 1 (HP, HV barley)	Extract 2 (HP, LV barley)	Extract 3 (HP, HV oat)	Extract 4 (HP, LV oat)	Extract 5 (MP, HV barley)
Jejunum
18:0	80±0.14	0.35±0.06	1.00±0.23	0.75±0.11	0.76±0.15	0.29±0.06
18:2	1.49±0.13	1.09±0.14	1.41±0.28	0.74±0.11^*	0.95±0.20	0.74±0.08^*
Cholesterol	0.80±0.06	0.65±0.08	0.71±0.07	0.64±0.04	0.87±0.09	0.37±0.05^*
Ileum
18:0	0.69±0.07	0.29±0.04^*	0.51±0.08	0.50±0.07	0.62±0.07	0.14±0.05^*
18:2	1.03±0.09	0.63±0.08^*	0.82±0.09	0.59±0.05^*	0.53±0.04^*	0.63±0.07^*
Cholesterol	0.73±0.05	0.57±0.11	0.63±0.06	0.63±0.04	0.66±0.10	0.34±0.05^*

The lipids were solubilized in 20 mM taurodeoxycholic acid. The number of animals in each group was 7–8 (mean±S.E.M.).

Extract 1=HP, HV barley β-glucan; Extract 2=HP, LV barley β-glucan; Extract 3=HP, HV oat β-glucan; Extract 4=HP, LV oat β-glucan; Extract 5=MP, HV barley β-glucan.

Significantly different from control (ANOVA, SNK multiple-range test: P<.05). Comparisons were made within each row.